Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Regulators of G protein signaling (RGS proteins) interact with Galpha(q) and Galpha(i) and accelerate GTPase activity. These proteins have been characterized only within the past few years, so our understanding of their importance is still preliminary. We examined the effect of
oxytocin
on
RGS2
mRNA expression to help determine the role of RGS proteins in
oxytocin
signaling in human myometrial cells in primary culture.
Oxytocin
increased
RGS2
mRNA concentration maximally by 1 or 2 h in a dose-dependent and agonist-specific manner.
RGS2
mRNA levels were also elevated by treatment with Ca(2+) ionophore, phorbol ester, or forskolin.
Oxytocin
's effects were completely inhibited by an intracellular Ca(2+) chelator and partially blocked by a protein kinase C inhibitor, indicating that intracellular Ca(2+) concentration is the primary signal for
oxytocin
elevation of
RGS2
mRNA levels. Use of pharmacological inhibitors indicated that part of
oxytocin
-stimulated
RGS2
mRNA expression is mediated by G(i)/tyrosine kinase activities. Although
oxytocin
does not stimulate increases in intracellular cAMP concentration, agents that elevate intracellular cAMP concentrations and cause myometrial relaxation may possibly cause heterologous desensitization to
oxytocin
via
RGS2
expression. These results suggest that
RGS2
may be important in regulating the myometrial response to
oxytocin
.
...
PMID:Oxytocin stimulation of RGS2 mRNA expression in cultured human myometrial cells. 1183 60
Serotonin 2A (5-HT2A) receptors are coupled to Galphaq and Galpha11 proteins to activate phospholipase C (PLC). Regulators of G-protein signaling proteins (RGS) modulate G-protein signaling by accelerating the intrinsic GTPase activity of Galphaq and Galpha11. This study investigated the effects of over-expression of wild-type Galphaq proteins (Gq-Tg) and over-expression of RGS-insensitive Galphaq proteins (G188S, RGSi-Tg) on 5-HT2A receptor mediated signaling in transgenic rats. Over-expression of wild-type Galphaq and RGS insensitive mutant Galphaq did not produce significant alterations in the levels of Galpha11,
RGS2
, RGS4, RGS7, RGS16 or 5-HT2A proteins. RGSi-Tg rats had higher
oxytocin
and corticosterone responses to (-)DOI, a 5-HT2A/2C receptor agonist, compared to Gq-Tg rats. RGSi-Tg and Gq-Tg rats had higher ACTH responses to (-)DOI compared to control rats. Similarly, 5-HT-stimulated PLC activity in the frontal cortex was higher in RGSi-Tg and Gq-Tg rats compared to control rats. In contrast, GTPgammaS-stimulated PLC activity was higher in Gq-Tg rats but not in RGSi-Tg rats compared to control rats. There was a small but statistically significant increase in the affinity of [125I]-DOI labeled 5-HT2A receptors in RGSi-Tg rats and Gq-Tg rats compared to controls. There were no significant differences in Bmax and Kd of [3H] ketanserin labeled 5-HT2A receptors among the three groups. These data suggest that the effect of RGS proteins on 5-HT2A receptor signaling is cell type specific. In transgenic rats over-expressing Galphaq, endogenous RGS proteins have a negative effect on 5-HT2A receptor-mediated
oxytocin
release. In contrast, endogenous RGS protein had no impact on 5-HT2A receptor-mediated ACTH release in transgenic rats.
...
PMID:Alterations in 5-HT2A receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein. 1676 91
Oxytocin
(
OXT
) is a peptide hormone that binds the
OXT
receptor on myometrial cells, initiating an intracellular signaling cascade, resulting in accumulation of intracellular calcium and smooth muscle contraction. In other systems, an elevation of intracellular Ca(2+) stimulates nuclear translocation of the transcription factor, nuclear factor of activated T cells (NFAT), which is transcriptionally active in arterial and ileal smooth muscle. Here we have investigated the role of NFAT in the mechanism of action of
OXT
. Human myometrial cells expressed all five NFAT isoforms (NFATC1-C4 and -5). Myometrial cells were transduced with a recombinant adenovirus expressing a NFATC1-EFP reporter, and a semi-automated imaging system was used to monitor effects of
OXT
on reporter localization in live cells.
OXT
induced a concentration-dependent nuclear translocation of NFATC1-EFP in a reversible manner, which was inhibited by
OXT
antagonists and calcineurin inhibitors. Pulsatile stimulation with
OXT
caused intermittent, pulse-frequency-dependent, nuclear translocation of NFATC1-EFP, which was more efficient than sustained stimulation.
OXT
induced nuclear translocation of endogenous NFAT that was transcriptionally active, because
OXT
stimulated activity of a NFAT-response element-luciferase reporter and induced calcineurin-NFAT dependent expression of
RGS2
, RCAN1, and PTGS2 (COX2) mRNA. Furthermore,
OXT
-dependent transcription was dependent on protein neosynthesis; cycloheximide abolished
RGS2
transcription but augmented RCAN1 and COX2 transcriptional readouts. This study identifies a novel signaling mechanism within the myometrium, whereby calcineurin-NFAT signaling mediates
OXT
-induced transcriptional activity. Furthermore, we show NFATC1-EFP is responsive to pulses of
OXT
, a mechanism by which myometrial cells could decode
OXT
pulse frequency.
...
PMID:Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells. 2290 39